News
USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...
2d
Pharmaceutical Technology on MSNDAAN Biotherapeutics and GC Cell agree on CAR-T, CAR-NK therapiesSouth Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...
While the first generation of CAR-T cells that have recently been approved in the US have proved to be highly effective, they are costly to make and administer. The CAR-T process involves several ...
For its final model year, the Firebird bowed out with what many call the best high-performance, factory-built bird of all ...
Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...
Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit ...
Gilead Sciences, Inc. ( NASDAQ: GILD) Q1 2025 Earnings Conference Call April 24, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...
On Route 220 in Henry County Sunday evening, Virginia State Trooper M.L. Gravely stopped to assist the driver of a disabled ...
Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...
The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Daniel O'Day: Chairman and Chief ...
We came across a bullish thesis on QuantumScape Corporation (QS) on Value Investing Subreddit Page by beerion. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results